Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Baricitinib set to join the Covid-19 therapeutic arsenal?
Gudu T, Stober C, Cope AP, Cheriyan J, Galloway J, Wilkinson IB, Kostapanos M, Jayne D, Hall F. Gudu T, et al. Among authors: wilkinson ib. Rheumatology (Oxford). 2021 Apr 6;60(4):1585-1587. doi: 10.1093/rheumatology/keab061. Rheumatology (Oxford). 2021. PMID: 33502499 Free PMC article. No abstract available.
Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humans.
Mackenzie IS, Maki-Petaja KM, McEniery CM, Bao YP, Wallace SM, Cheriyan J, Monteith S, Brown MJ, Wilkinson IB. Mackenzie IS, et al. Among authors: wilkinson ib. Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1891-5. doi: 10.1161/01.ATV.0000179599.71086.89. Epub 2005 Jul 28. Arterioscler Thromb Vasc Biol. 2005. PMID: 16051882 Clinical Trial.
Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction.
Wallace SM, Mäki-Petäjä KM, Cheriyan J, Davidson EH, Cherry L, McEniery CM, Sattar N, Wilkinson IB, Kharbanda RK. Wallace SM, et al. Among authors: wilkinson ib. Br J Clin Pharmacol. 2010 Dec;70(6):799-806. doi: 10.1111/j.1365-2125.2010.03745.x. Br J Clin Pharmacol. 2010. PMID: 21175435 Free PMC article. Clinical Trial.
Inhibition of p38 mitogen-activated protein kinase improves nitric oxide-mediated vasodilatation and reduces inflammation in hypercholesterolemia.
Cheriyan J, Webb AJ, Sarov-Blat L, Elkhawad M, Wallace SM, Mäki-Petäjä KM, Collier DJ, Morgan J, Fang Z, Willette RN, Lepore JJ, Cockcroft JR, Sprecher DL, Wilkinson IB. Cheriyan J, et al. Among authors: wilkinson ib. Circulation. 2011 Feb 8;123(5):515-23. doi: 10.1161/CIRCULATIONAHA.110.971986. Epub 2011 Jan 24. Circulation. 2011. PMID: 21262998 Clinical Trial.
Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis.
Elkhawad M, Rudd JH, Sarov-Blat L, Cai G, Wells R, Davies LC, Collier DJ, Marber MS, Choudhury RP, Fayad ZA, Tawakol A, Gleeson FV, Lepore JJ, Davis B, Willette RN, Wilkinson IB, Sprecher DL, Cheriyan J. Elkhawad M, et al. Among authors: wilkinson ib. JACC Cardiovasc Imaging. 2012 Sep;5(9):911-22. doi: 10.1016/j.jcmg.2012.02.016. JACC Cardiovasc Imaging. 2012. PMID: 22974804 Free article. Clinical Trial.
308 results